Bridgebio Oncology TherapeutBBOT
13F holders, Q3 2025 (September 30)42holders
2famous investors
$11.57avg. 13F price*
At the end of Q3 2025, 42 institutions reported holding Bridgebio Oncology Therapeut (BBOT) in their 13F filings. The largest holders were Cormorant Asset Management, LP ($207.0M), Deerfield Management Company, L.P. ($56.6M) and Omega Fund Management, LLC ($38.1M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Bridgebio Oncology Therapeut
- CUSIP
- 107924102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 42 | $657.5M |
| Exits | 0 | $0 |
Ownership 42 holders
| Cormorant Asset Management, LP | 14.29% | New | 17,878,594 | $207.0M |
| Deerfield Management Company, L.P. | 0.94% | New | 4,885,446 | $56.6M |
| Omega Fund Management, LLC | 17.13% | New | 3,289,661 | $38.1M |
| Wellington Management Group LLP | 0.01% | New | 2,961,263 | $34.3M |
| EcoR1 Capital, LLC | 1.57% | New | 2,823,126 | $32.7M |
| Alphabet Inc. | 1.36% | New | 2,823,126 | $32.7M |
| Enavate Sciences Gp, LLC | 9.29% | New | 2,626,946 | $30.4M |
| Citadel Advisors | 0.02% | New | 2,538,141 | $29.4M |
| BlackRock, Inc. | 0.00% | New | 2,048,552 | $23.7M |
| Novo Holdings A/S | 1.46% | New | 1,961,317 | $22.7M |
| Paradigm Biocapital Advisors LP | 0.64% | New | 1,866,141 | $21.6M |
| Adage Capital Partners Gp, L.L.C. | 0.03% | New | 1,487,621 | $17.2M |
| Eventide Asset Management, LLC | 0.20% | New | 1,082,362 | $12.4M |
| Laurion Capital Management LP | 1.78% | New | 1,045,800 | $12.1M |
| Octagon Capital Advisors LP | 1.89% | New | 1,043,110 | $12.1M |
| T. Rowe Price Associates Inc. | 0.00% | New | 885,042 | $10.2M |
| Vanguard Group Inc. | 0.00% | New | 647,599 | $7.5M |
| Aisling Capital Management LP | 1.43% | New | 564,625 | $6.5M |
| Geode Capital Management, LLC | 0.00% | New | 541,602 | $6.3M |
| ADAR1 Capital Management, LLC | 0.58% | New | 501,228 | $5.8M |
| Silverarc Capital Management, LLC | 0.77% | New | 457,414 | $5.3M |
| Armistice Capital, LLC | 0.15% | New | 412,000 | $4.8M |
| Millennium Management | 0.00% | New | 369,563 | $4.1M |
| Casdin Capital, LLC | 0.27% | New | 282,312 | $3.3M |
| Charles Schwab Investment Management Inc. | 0.00% | New | 279,350 | $3.2M |
| Ikarian Capital, LLC | 0.57% | New | 245,231 | $2.8M |
| Stempoint Capital LP | 0.44% | New | 186,614 | $2.2M |
| State Street Corp. | 0.00% | New | 176,695 | $2.0M |
| FMR LLC | 0.00% | New | 162,077 | $1.9M |
| Sio Capital Management, LLC | 0.38% | New | 130,628 | $1.5M |
| TD Asset Management Inc | 0.00% | New | 130,062 | $1.5M |
| Woodline Partners LP | 0.01% | New | 103,707 | $1.2M |
| Moore Capital Management, LP | 0.02% | New | 100,000 | $1.2M |
| Boothbay Fund Management, LLC | 0.03% | New | 96,551 | $1.1M |
| Northern Trust Corp. | 0.00% | New | 95,957 | $1.1M |
| UBS Group AG | 0.00% | New | 52,226 | $605K |
| XTX Topco Ltd | 0.01% | New | 23,384 | $271K |
| China Universal Asset Management Co., Ltd. | 0.00% | New | 5,000 | $58K |
| Bank of America Corp. | 0.00% | New | 1,329 | $15K |
| Morgan Stanley | 0.00% | New | 861 | $10K |
| FNY Investment Advisers, LLC | 0.00% | New | 100 | $1K |
| Royal Bank of Canada | 0.00% | New | 16 | $0 |
"% of holder's portfolio" is BBOT's weight in each manager's 13F, not the share of Bridgebio Oncology Therapeut the manager owns.